ALDH1B1
Basic information
Region (hg38): 9:38392702-38398661
Previous symbols: [ "ALDH5" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (58 variants)
- not_provided (16 variants)
- Complex_neurodevelopmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALDH1B1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000692.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 60 | 64 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 1 | 60 | 4 | 5 |
Highest pathogenic variant AF is 0.000037177
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALDH1B1 | protein_coding | protein_coding | ENST00000377698 | 1 | 5998 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000270 | 0.532 | 122182 | 70 | 3496 | 125748 | 0.0143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.227 | 333 | 322 | 1.04 | 0.0000208 | 3366 |
Missense in Polyphen | 106 | 105.44 | 1.0053 | 1235 | ||
Synonymous | 0.494 | 133 | 140 | 0.947 | 0.00000925 | 1092 |
Loss of Function | 0.781 | 10 | 13.0 | 0.767 | 7.25e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0729 | 0.0729 |
Ashkenazi Jewish | 0.0139 | 0.0140 |
East Asian | 0.00109 | 0.00109 |
Finnish | 0.00129 | 0.00129 |
European (Non-Finnish) | 0.00790 | 0.00787 |
Middle Eastern | 0.00109 | 0.00109 |
South Asian | 0.00297 | 0.00294 |
Other | 0.0166 | 0.0168 |
dbNSFP
Source:
- Function
- FUNCTION: ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde. They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Pyruvate metabolism - Homo sapiens (human);Arginine and proline metabolism - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Glycerolipid metabolism - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Lysine degradation - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Disulfiram Action Pathway;Ethanol Degradation;Phase I - Functionalization of compounds;Glutamate Glutamine metabolism;Glycolysis and Gluconeogenesis;Leukotriene metabolism;Ethanol oxidation;Biological oxidations;Metabolism;Lysine degradation;Propanoate metabolism;2,-deoxy-α-D-ribose 1-phosphate degradation;Histidine metabolism;Lysine metabolism;Tryptophan metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Valine, leucine and isoleucine degradation;Butanoate metabolism;Propanoate metabolism;Bile acid biosynthesis;Glycerophospholipid metabolism;Arginine Proline metabolism;Pyruvate metabolism;Tryptophan degradation;Valine Leucine Isoleucine degradation;Histidine degradation;putrescine degradation III
(Consensus)
Recessive Scores
- pRec
- 0.453
Intolerance Scores
- loftool
- 0.574
- rvis_EVS
- -0.04
- rvis_percentile_EVS
- 50.45
Haploinsufficiency Scores
- pHI
- 0.674
- hipred
- N
- hipred_score
- 0.248
- ghis
- 0.513
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.642
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Aldh1b1
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- carbohydrate metabolic process;ethanol catabolic process;ethanol oxidation
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial matrix;intracellular membrane-bounded organelle
- Molecular function
- aldehyde dehydrogenase (NAD) activity;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;NAD binding